VIAV · Viavi Solutions
Conviction · Medium · more likely to lead the S&P 500 over the next three months, by a modest margin
Wrong if: a daily close below $26.30
Note written ·
How this view changed
- · Rating raised from Low to Medium. Results, 4 November 2026: Viavi reported fiscal first-quarter 2027 revenue of $469.3 million against a $450–460 million guide and guided fiscal second-quarter revenue to $505–515 million against a $467.63 million analyst estimate.
Price against the kill line
16.8% clear of its kill line on the 13 November 2026 close.
How to read this
The red mark is the price level of the published kill line: a close through it (a weekly close, on a weekly line) would prove the research note wrong on price. The dot is where the stock closed on 13 November 2026; a dot left of the mark has closed through its line.
The scale is stretched near the line, so close calls are easy to see. More than 8% from the line, the stock reads well clear, with a hollow dot to show the figure is off the drawn scale.
The kill line is the research note's own test. The portfolio sells on business facts, not on a price. How the portfolio decides
Three months against the kill line
Daily closes, to . Red: the kill line, a daily close below $26.30, set on 12 November 2026. The shares are down 33.6% since the close; the S&P 500 is down 2.1% over the same sessions. Figures in the note can cover a different window.
Kill line
A daily close below $26.30, the 5 November 2026 post-earnings closing low, which would erase the whole rebound and show the market rejecting the beat-and-raise report. Fiscal second-quarter revenue below the $505 million low end of the guide would also show the case failing.
Research onlyNot in the portfolio.
Key figures from the filings · Technology
Quarter to 3 October 2026, filed 5 November 2026; valuation at the 13 November 2026 close
- Revenue, latest quarter ($M)
- 469
- Revenue, change on a year (%)
- +56.9
- Gross margin (%)
- 61.2
- Operating margin (%)
- 17.4
- Free cash flow, four quarters ($M)
- 153
- Net cash, cash less debt ($M)
- 131
- Price to earnings (×)
- 112.8
- Enterprise value to sales (×)
- 4.4
All filed numbers
What Viavi Solutions reports to the SEC in its quarterly and annual filings. Each group states its period and filing date once; a figure dated otherwise says so. Built from the filings known on .
| Quarter to | Revenue ($M) | On a year (%) | Gross margin (%) | Operating margin (%) |
|---|---|---|---|---|
| first filed | 469 | +56.9 | 61.2 | 17.4 |
| first filed | 443 | +52.5 | 59.1 | 13.8 |
| first filed | 407 | +42.8 | 57.5 | 6.1 |
| first filed | 369 | +36.4 | 57.0 | 3.1 |
| first filed | 299 | +25.6 | 56.5 | 2.5 |
| first filed | 291 | +15.3 | 56.3 | 5.3 |
| Pre-tax income ($M) | 86.3 |
| Net income ($M) four quarters: 67.0 | 76.0 |
| Diluted shares, change on a year (%) against the quarter to 27 September 2025 | +19.4 |
| Operating cash flow ($M) | 188 |
| Capital spending ($M) | 34.6 |
| Free cash flow ($M) | 153 |
| Cash and short-term investments ($M) | 529 |
| Debt ($M) long-term debt | 397 |
| Net cash, cash less debt ($M) | 131 |
| Deferred revenue ($M) +53.1% on a year | 140 |
| Backlog, orders not yet delivered ($M) +88.4% on a year | 664 |
| Receivables ($M) | 335 |
| Inventory ($M) | 174 |
| Shareholders' equity ($M) | 1,324 |
| Market value ($M) | 7,555 |
| Enterprise value, market value plus net debt ($M) | 7,423 |
| Enterprise value to sales (×) | 4.4 |
| Enterprise value to operating income (×) | 41.4 |
| Price to earnings (×) | 112.8 |
| Price to book value (×) | 5.7 |
| Free-cash-flow yield (%) | 2.0 |
Short interest (FINRA, settled 15 October 2026, published 26 October 2026): 4.9% of shares outstanding sold short, 2.2 days of average trading to cover, −8.7% since the previous report.
| Window | Bought | Sold |
|---|---|---|
| 90 daysfrom | $0 | $5.1M |
| 12 monthsfrom | $0 | $57.8M |
The thesis
Viavi Solutions' shares are more likely than not to beat the S&P 500 over the next three months. The 4 November 2026 fiscal first-quarter report beat its guide and lifted the outlook well above analyst estimates, and the shares remain 45.4% below their 52-week high. The fiscal second-quarter report in early February 2027 settles whether revenue reaches the guided $505–515 million.
Viavi reported revenue of $469.3 million for the quarter that ended 3 October 2026, against its own $450–460 million guide. Adjusted earnings were $0.47 per share against the $0.40–0.42 guide. Viavi guided fiscal second-quarter revenue to $505–515 million and adjusted earnings to $0.50–0.52 per share. Headlines on 4 November 2026 put analyst estimates at $467.63 million and $0.40.
The market sold the news first. The shares closed at $29.38 on 4 November 2026, the day of the after-the-close report, then fell 10.48% on 5 November 2026, according to Finviz. They rose in each of the next sessions except 10 November 2026 and closed at $33.00 on 11 November 2026. That is still below both the 50-day average of $36.44 and the 200-day average of $39.17, and the 3-month change is −23.2%.
The price already reflects deep doubt about AI infrastructure spending: the shares closed at $33.00 on 11 November 2026, 45.4% under the $60.43 intraday high of 30 April 2026, even after a guide that sits above the $467.63 million estimate.
Bullish and bearish views on Viavi Solutions Inc.
The bull case on Viavi Solutions Inc. (VIAV), in brief: the quarter beat on revenue and profit. The bear case: the shares fell on a beat-and-raise.
Bull case
- The quarter beat on revenue and profit. Revenue of $469.3 million rose 56.9% from a year earlier and 5.9% from the prior quarter, per Viavi's 4 November 2026 release. Network and Service Enablement revenue was $376.1 million, up 74.1%.
- The guide implies growth beyond the extra week. The quarter that ended 3 October 2026 ran 14 weeks. The fiscal second-quarter guide of $505–515 million still sits above first-quarter revenue, which answers the concern that the extra week flattered the quarter. Viavi now expects a $500 million quarterly revenue run rate in the December quarter, a goal a Finviz report on 5 November 2026 said had earlier been framed for later.
- Margins and cash improved. Non-GAAP operating margin was 29.0%, up 1,270 basis points from a year earlier. Operating cash flow was $104.7 million and cash, short-term investments and restricted cash totalled $535.3 million, per the release.
- Repurchases add demand for the shares. Viavi's board authorized a new $500 million repurchase program on 1 November 2026. About $18.4 million remained under the earlier $300 million plan, per the release.
- Management reports no slowdown. Finviz reported on 5 November 2026 that management said on the earnings call it saw no sign of weaker demand, after analysts asked about the durability of AI and data-center spending.
Bear case
- The shares fell on a beat-and-raise. The 10.48% drop on 5 November 2026 came after a report above guidance. Finviz attributed the weakness mainly to doubt about AI infrastructure spending, which is the article's reading, not a company disclosure.
- Analysts trimmed targets after the report. UBS kept a Neutral rating and lowered its target to $33 on 6 November 2026. Needham kept a Buy rating and lowered its target to $53 on 5 November 2026.
- Part of the margin gain did not come from operations. Finviz reported that a one-time tariff refund of about $11 million added roughly 110 basis points to operating margin. The same article noted weaker Wireless results and a seasonally lower outlook for Optical Security and Performance Products.
- Supply sits overhead. Viavi sold shares in an offering priced at $45.00 in May 2026. The 200-day average of $39.17 and the $45.00 price both sit above the last close of $33.00.
- Insiders have sold. Luke Scrivanich, a senior vice president, sold 35,866 shares at $36.24 on 23 September 2026 under a Rule 10b5-1 plan, per SEC Form 4. GuruFocus reported on 16 October 2026 that insiders sold $59.8 million of stock over 12 months and bought none.
- Debt is larger than cash. The release put the net carrying value of debt at $642.5 million against $535.3 million of cash and investments. Finviz said about $245 million of convertible notes sit in short-term debt.
Price setup
The shares closed at $33.00 on 11 November 2026, up from $31.01 on 10 November 2026 and $31.98 on 9 November 2026. Closes on 6 November 2026 and 5 November 2026 were $28.47 and the post-report low, a rebound of roughly a quarter from the low within four sessions.
Three levels sit overhead, all from adjusted daily closes or the offering terms: the 50-day average of $36.44, the 200-day average of $39.17 (both as of 11 November 2026), and the $45.00 offering price. The 52-week intraday high is $60.43 on 30 April 2026. The 52-week closing low is $15.92 on 20 November 2025.
The shares gave up about 23% in three months while estimates for the next quarter rose. The 10-Q, filed 5 November 2026, and the 8-K of 4 November 2026 are the filed record of the quarter.
Catalysts ahead
- ~4 February 2027 (est.): Fiscal second-quarter 2027 results (date not yet announced). Shows whether Viavi delivered the guided $505–515 million of revenue and the $500 million quarterly run rate that management now expects in the December quarter.
What would change the view
A daily close below $26.30, the 5 November 2026 post-earnings closing low, which would erase the whole rebound and show the market rejecting the beat-and-raise report. Fiscal second-quarter revenue below the $505 million low end of the guide would also show the case failing.
The risks this note tracks, each with what would confirm it:
- Doubt about AI and data-center spending keeps pressuring optical and network-equipment shares regardless of Viavi's own results. Confirmed by: a large cloud customer guiding capital spending down at a quarterly report, or another sharp single-session fall in the shares without company news.
- Viavi fails to deliver the guided December-quarter revenue. Confirmed by: fiscal second-quarter 2027 revenue below the $505 million low end of the guide at the early-February 2027 report.
- Margin quality is weaker than the headline because of one-time items such as the tariff refund. Confirmed by: Non-GAAP operating margin in fiscal second-quarter 2027 falling below the 29.0% reported for the first quarter.
- Supply from the May 2026 offering and the 200-day average cap any recovery. Confirmed by: rallies that fail at the 200-day average of $39.17 or below the $45.00 offering price over the next quarter.
- Insider selling continues after the report. Confirmed by: new SEC Form 4 filings showing open-market insider sales after the 4 November 2026 report.
- Debt maturities, including about $245 million of convertible notes cited as short-term debt, force costly refinancing or reduce buybacks. Confirmed by: a refinancing on worse terms or a reduced buyback pace disclosed in a later 10-Q.
What it trades with
Viavi trades with the optical and AI-network equipment group, and its test equipment sells into AI-related network build-outs. Analyst questions on the 4 November 2026 call about AI and data-center spending show the same sentiment that moved the shares on 5 November 2026. Viavi's fiscal calendar differs from most peers, so its report arrives after their updates have set the tone for the group.
The evidence, claim by claim (8)
- Viavi fiscal Q1 2027 revenue was $469.3M, up 56.9% year over year and 5.9% sequentially; non-GAAP diluted EPS was $0.47 and GAAP diluted EPS $0.29. VIAVI fiscal Q1 2027 results release, 4 November 2026 · as of
- Viavi guided fiscal Q2 2027 revenue to $505–515M and non-GAAP EPS to $0.50–0.52, against estimates of $467.63M and $0.40 cited in 4 November 2026 headlines. VIAVI results release and Q2 guidance headline, 4 November 2026 · as of
- Non-GAAP operating margin was 29.0%, up 1,270 bp year over year; operating cash flow was $104.7M; cash, short-term investments and restricted cash were $535.3M. VIAVI fiscal Q1 2027 results release, 4 November 2026 · as of
- Viavi's board authorized a new $500M share repurchase program on 1 November 2026; about $18.4M remained under the earlier $300M plan. VIAVI fiscal Q1 2027 results release, 4 November 2026 · as of
- A one-time tariff refund of about $11M contributed roughly 110 bp of Q1 operating margin; Viavi shares fell 10.48% on 5 November 2026. Finviz, 5 November 2026 · as of
- UBS maintained Neutral and lowered its Viavi price target to $33; Needham maintained Buy and lowered its target to $53. Benzinga headlines, 5 November 2026 and 6 November 2026 · as of
- Luke Scrivanich, SVP General Manager OSP, sold 35,866 shares at $36.24 on 23 September 2026 under a Rule 10b5-1 plan. SEC Form 4, filed 23 September 2026 · as of
- Viavi filed its 10-Q for the quarter ended 3 October 2026 and an 8-K with results on 4 November 2026. SEC EDGAR · as of
Sources
- VIAVI Announces First Quarter Fiscal 2027 Results · finviz.com
- Finviz
Related · shared themes
ANET
Arista Networks
Arista Networks' guide for about $18.5 billion of 2027 revenue, near 40% growth, gives its shares a modest edge over the S&P 500 after a…
MRVL
Marvell Technology
Marvell Technology shares are more likely to lag the S&P 500 over the next three months because merger arbitrage gives its $115 billion…
ALAB
Astera Labs
Astera Labs shares are modestly more likely than not to beat the S&P 500: third-quarter revenue of $584.9 million beat guidance and the…
AXTI
AXT
AXT, Inc.'s indium-phosphide substrate demand (record $73.41M quarter, about $90M guided for Q4) favors the shares over three months; Q4…